Vivos (RDGL) Research & Development (2010 - 2025)
Vivos (RDGL) posted Research & Development of $57166.0 for Q4 2025, down 15.71% sequentially from $67820.0 in Q3 2025, and down 43.38% YoY from $100969.0 in Q4 2024.
Vivos (RDGL) Research & Development (2010 - 2025) Analysis & Trends
Vivos has reported Research & Development for 15 years, with the latest figure at $57166.0 in Q4 2025.
- Quarterly Research & Development fell 43.38% year-over-year to $57166.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $352232.0 (up 8.5% YoY) and the FY2025 annual result came in at $352232.0, up 8.5% from the prior year.
- Research & Development retreated to $57166.0 in Q4 2025 per RDGL's latest filing, from $67820.0 in the prior quarter.
- Over five years, Research & Development peaked at $432112.0 in Q4 2023 and troughed at $31736.0 in Q4 2022.
- A 5-year average of $102060.5 and a median of $72134.5 in 2021 frame the typical range for Research & Development.
- The sharpest annual moves came in 2021 and 2024: Research & Development jumped 6874.71% in 2021, then tumbled 76.63% in 2024.
- Over 5 years, Research & Development stood at $65694.0 in 2021, then slumped by 51.69% to $31736.0 in 2022, then soared by 1261.58% to $432112.0 in 2023, then sank by 76.63% to $100969.0 in 2024, then plunged by 43.38% to $57166.0 in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $57166.0, $67820.0, and $107965.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 57,166.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,166.00 |
| Sep 30, 2025 | 67,820.00 |
| Jun 30, 2025 | 107,965.00 |
| Mar 31, 2025 | 119,281.00 |
| Dec 31, 2024 | 100,969.00 |
| Sep 30, 2024 | 66,551.00 |
| Jun 30, 2024 | 99,662.00 |
| Mar 31, 2024 | 57,447.00 |
| Dec 31, 2023 | 432,112.00 |
| Sep 30, 2023 | 80,858.00 |
| Jun 30, 2023 | 173,353.00 |
| Mar 31, 2023 | 46,375.00 |
| Dec 31, 2022 | 31,736.00 |
| Sep 30, 2022 | 70,765.00 |
| Jun 30, 2022 | 169,732.00 |
| Mar 31, 2022 | 72,569.00 |
| Dec 31, 2021 | 65,694.00 |
| Sep 30, 2021 | 60,831.00 |
| Jun 30, 2021 | 88,624.00 |
| Mar 31, 2021 | 71,700.00 |